HomeCYTH • NASDAQ
add
Cyclo Therapeutics Inc
Previous close
$0.70
Day range
$0.68 - $0.77
Year range
$0.59 - $2.12
Market cap
20.37M USD
Avg Volume
25.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 233.77K | -52.82% |
Operating expense | 8.50M | 62.79% |
Net income | -8.83M | -85.12% |
Net profit margin | -3.78K | -292.37% |
Earnings per share | — | — |
EBITDA | -8.29M | -74.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 928.01K | -48.50% |
Total assets | 5.25M | -6.13% |
Total liabilities | 18.73M | 181.62% |
Total equity | -13.47M | — |
Shares outstanding | 28.77M | — |
Price to book | -1.49 | — |
Return on assets | -415.63% | — |
Return on capital | 1,221.21% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -8.83M | -85.12% |
Cash from operations | -8.19M | -102.72% |
Cash from investing | — | — |
Cash from financing | 8.00M | 59.92% |
Net change in cash | -193.80K | -120.18% |
Free cash flow | -4.50M | -83.58% |
About
Founded
1990
Headquarters
Website
Employees
8
